References
- American Psychiatric Association. The practice of electroconvulsive therapy. Recommendations for treatment, training, and privileging. American Psychiatric Association, Washington, DC 2001; 81–95
- Braga JB, Petrides G. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J ECT 2005; 21: 75–83
- Burris KD, Molski TF, Xu C, et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002; 302: 381–389
- Lieberman JA. Dopamine partial agonists: a new class of antipsychotic. Drugs 2004; 18: 251–267
- Painuly N, Chakrabarti S. Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis. J ECT 2006; 22: 59–66